Abstract:Background According to the pathoanatomic classification system, progressive hemorrhagic injury (PHI) can be categorized into progressive intraparenchymal contusion or hematoma (pIPCH), epidural hematoma (pEDH), subdural hematoma (pSDH), and traumatic subarachnoid hemorrhage (ptSAH). The clinical features of each type differ greatly. The objective of this study was to determine the predictors, clinical management, and outcomes of PHI according to this classification. Methods Multivariate logistic regression analysis was used to identify independent risk factors for PHI and each subgroup. Patients with IPCH or EDH were selected for subgroup propensity score matching (PSM) to exclude confounding factors before evaluating the association of hematoma progression with the outcomes by classification. Results In the present cohort of 419 patients, 123 (29.4%) demonstrated PHI by serial CT scan. Of them, progressive ICPH (58.5%) was the most common type, followed by pEDH (28.5%), pSDH (9.8%), and ptSAH (3.2%). Old age (≥ 60 years), lower motor Glasgow Coma Scale score, larger primary lesion volume, and higher level of D-dimer were independent risk factors related to PHI. These factors were also independent predictors for pIPCH, but not for pEDH. The time to first CT scan and presence of skull linear fracture were robust risk factors for pEDH. After PSM, the 6-month mortality and unfavorable survival rates were significantly higher in the pIPCH group than the non-pIPCH group (24.2% vs. 1.8% and 12.1% vs. 7.3%, respectively, p < 0.001), but not significantly different between the pEDH group and the non-pEDH group. Conclusions Understanding the specific patterns of PHI according to its classification can help early recognition and suggest targeted prevention or treatment strategies to improve patients’ neurological outcomes.

Research Progress on Progressive Brain Injury after Traumatic Brain Injury

[Injury mechanism, clinical status and prospects of traumatic brain injury]

Research progress on pleiotropic neuroprotective drugs for traumatic brain injury

Mechanism of action of oxidative stress in severe traumatic brain injury and its complications: recent progress

Research progress in progressive hemorrhagic injury following head trauma

Research Progress of Brain Ischemic Injury Protective Agents

Analysis of Risk Factors of Intracranial Progressive Hemorrhage after Traumatic Brain Injury

Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage

Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia

Contusion Progression Following Traumatic Brain Injury: A Review of Clinical and Radiological Predictors, and Influence on Outcome

Early Brain Injury and Neuroprotective Treatment after Aneurysmal Subarachnoid Hemorrhage: A Literature Review

Research progress in CT scoring system early predicting prognosis of patients with craniocerebral trauma

Pathogenesis and treatment progress of coagulation dysfunction after traumatic brain injury

Research progress in secondary brain damage mechanisms after traumatic brain injury

Research Progress on Mechanism of Ischemic Stroke Injury

Progress of the therapy of the intracerebral hemorrhage

Classification, Risk Factors, and Outcomes of Patients with Progressive Hemorrhagic Injury after Traumatic Brain Injury

Traumatic brain injuries: a neuropsychological review

Recent Advances in Biomaterials‐Based Therapies for Alleviation and Regeneration of Traumatic Brain Injury

Correlation Between Coagulation-Fibrinolysis and Progressive Intracranial Hemorrhage and Prognosis in Patients with Acute Traumatic Brain Injury

[Advances in molecular mechanisms and therapeutic strategies of white matter injury after intracerebral hemorrhage]